247 related articles for article (PubMed ID: 2522791)
1. Effect of medroxyprogesterone acetate on the response of the rat mammary gland to carcinogenesis.
Russo IH; Gimotty P; Dupuis M; Russo J
Br J Cancer; 1989 Feb; 59(2):210-6. PubMed ID: 2522791
[TBL] [Abstract][Full Text] [Related]
2. Hormone prevention of mammary carcinogenesis by norethynodrel-mestranol.
Russo IH; Frederick J; Russo J
Breast Cancer Res Treat; 1989 Oct; 14(1):43-56. PubMed ID: 2513893
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of the mammary gland to carcinogenesis. II. Pregnancy interruption as a risk factor in tumor incidence.
Russo J; Russo IH
Am J Pathol; 1980 Aug; 100(2):497-512. PubMed ID: 6773421
[TBL] [Abstract][Full Text] [Related]
4. Effect of human chorionic gonadotropin on mammary gland differentiation and carcinogenesis.
Russo IH; Koszalka M; Russo J
Carcinogenesis; 1990 Oct; 11(10):1849-55. PubMed ID: 2119909
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of the mammary gland to carcinogenesis: I Differentiation of the mammary gland as determinant of tumor incidence and type of lesion.
Russo J; Wilgus G; Russo IH
Am J Pathol; 1979 Sep; 96(3):721-36. PubMed ID: 112872
[TBL] [Abstract][Full Text] [Related]
6. Curcumin delays development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz[a]anthracene-induced mammary tumors.
Carroll CE; Benakanakere I; Besch-Williford C; Ellersieck MR; Hyder SM
Menopause; 2010; 17(1):178-84. PubMed ID: 19629015
[TBL] [Abstract][Full Text] [Related]
7. Progestagens and mammary gland development: differentiation versus carcinogenesis.
Russo IH; Russo J
Acta Endocrinol (Copenh); 1991; 125 Suppl 1():7-12. PubMed ID: 1839345
[TBL] [Abstract][Full Text] [Related]
8. Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.
Benakanakere I; Besch-Williford C; Schnell J; Brandt S; Ellersieck MR; Molinolo A; Hyder SM
Clin Cancer Res; 2006 Jul; 12(13):4062-71. PubMed ID: 16818706
[TBL] [Abstract][Full Text] [Related]
9. [Combined therapies with medroxyprogesterone acetate (MPA) in DMBA-induced rat mammary cancer].
Ishikawa H; Iino Y; Izuo M; Takikawa H
Gan No Rinsho; 1986 Feb; 32(2):151-5. PubMed ID: 2937941
[TBL] [Abstract][Full Text] [Related]
10. Angiogenic activity of rat mammary carcinomas induced by 7,12-dimethylbenz[a]anthracene and its inhibition by medroxyprogesterone acetate: possible involvement of antiangiogenic action of medroxyprogesterone acetate in its tumor growth inhibition.
Oikawa T; Hiragun A; Yoshida Y; Ashino-Fuse H; Tominaga T; Iwaguchi T
Cancer Lett; 1988 Dec; 43(1-2):85-92. PubMed ID: 2462464
[TBL] [Abstract][Full Text] [Related]
11. Sequential hormone therapy with medroxyprogesterone acetate for 7, 12-dimethylbenz [alpha] anthracene-induced rat mammary tumors.
Iino Y; Ishikawa H; Izuo M; Takikawa H
Jpn J Clin Oncol; 1989 Mar; 19(1):45-50. PubMed ID: 2522157
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of chorionic gonadotropin on DMBA-induced mammary carcinogenesis.
Russo IH; Koszalka M; Gimotty PA; Russo J
Br J Cancer; 1990 Aug; 62(2):243-7. PubMed ID: 2117463
[TBL] [Abstract][Full Text] [Related]
13. Developmental stage of the rat mammary gland as determinant of its susceptibility to 7,12-dimethylbenz[a]anthracene.
Russo IH; Russo J
J Natl Cancer Inst; 1978 Dec; 61(6):1439-49. PubMed ID: 102856
[TBL] [Abstract][Full Text] [Related]
14. Controlled release low dose medroxyprogesterone acetate (MPA) inhibits the development of mammary tumors induced by dimethyl-benz(a) anthracene in the rat.
Labrie F; Li S; Bélanger A; Côté J; Mérand Y; Lepage M
Breast Cancer Res Treat; 1993; 26(3):253-65. PubMed ID: 8251650
[TBL] [Abstract][Full Text] [Related]
15. Inhibition by 9alpha-fluoromedoroxyprogesterone acetate (FMPA) against mammary carcinoma induced by dimethylbenz[a]anthracene in rats and angiogenesis in the rabbit cornea - comparison with medroxyprogesterone acetate (MPA).
Uchida M; Tsuboi H; Yamaji T; Murata N; Kohno T; Sugino E; Hibino S; Shimamura M; Oikawa T
Cancer Lett; 2000 Jun; 154(1):63-9. PubMed ID: 10799740
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility of the mammary gland to carcinogenesis. III. The cell of origin of rat mammary carcinoma.
Russo J; Tait L; Russo IH
Am J Pathol; 1983 Oct; 113(1):50-66. PubMed ID: 6312803
[TBL] [Abstract][Full Text] [Related]
17. Medroxyprogesterone acetate accelerates the development and increases the incidence of mouse mammary tumors induced by dimethylbenzanthracene.
Aldaz CM; Liao QY; LaBate M; Johnston DA
Carcinogenesis; 1996 Sep; 17(9):2069-72. PubMed ID: 8824536
[TBL] [Abstract][Full Text] [Related]
18. Influence of caffeine on development of benign and carcinomatous mammary gland tumors in female rats treated with the carcinogens 7,12-dimethylbenz(a)anthracene and N-methyl-N-nitrosourea.
VanderPloeg LC; Wolfrom DM; Welsch CW
Cancer Res; 1991 Jul; 51(13):3399-404. PubMed ID: 1905195
[TBL] [Abstract][Full Text] [Related]
19. Basis of cellular autonomy in the susceptibility to carcinogenesis.
Russo J
Toxicol Pathol; 1983; 11(2):149-66. PubMed ID: 6443045
[TBL] [Abstract][Full Text] [Related]
20. Synthetic progestins differentially promote or prevent 7,12-dimethylbenz(a)anthracene-induced mammary tumors in sprague-dawley rats.
Benakanakere I; Besch-Williford C; Carroll CE; Hyder SM
Cancer Prev Res (Phila); 2010 Sep; 3(9):1157-67. PubMed ID: 20699413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
